Aducanumab: A Deep Dive into BIIB037 and its Impact This drug, previously known as BIIB037, represents a complex effort to combat emerging Alzheimer's disease. Developed by Biogen, aducanumab functions by removing https://www.targetmol.com/compound/aducanumab